Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

151 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
IL-2 therapy restores regulatory T-cell dysfunction induced by calcineurin inhibitors.
Whitehouse G, Gray E, Mastoridis S, Merritt E, Kodela E, Yang JHM, Danger R, Mairal M, Christakoudi S, Lozano JJ, Macdougall IC, Tree TIM, Sanchez-Fueyo A, Martinez-Llordella M. Whitehouse G, et al. Proc Natl Acad Sci U S A. 2017 Jul 3;114(27):7083-7088. doi: 10.1073/pnas.1620835114. Epub 2017 Jun 5. Proc Natl Acad Sci U S A. 2017. PMID: 28584086 Free PMC article.
Prospective multicenter clinical trial of immunosuppressive drug withdrawal in stable adult liver transplant recipients.
Benítez C, Londoño MC, Miquel R, Manzia TM, Abraldes JG, Lozano JJ, Martínez-Llordella M, López M, Angelico R, Bohne F, Sese P, Daoud F, Larcier P, Roelen DL, Claas F, Whitehouse G, Lerut J, Pirenne J, Rimola A, Tisone G, Sánchez-Fueyo A. Benítez C, et al. Among authors: whitehouse g. Hepatology. 2013 Nov;58(5):1824-35. doi: 10.1002/hep.26426. Epub 2013 Sep 19. Hepatology. 2013. PMID: 23532679 Clinical Trial.
Immunosuppression withdrawal following liver transplantation.
Whitehouse GP, Sanchez-Fueyo A. Whitehouse GP, et al. Clin Res Hepatol Gastroenterol. 2014 Dec;38(6):676-80. doi: 10.1016/j.clinre.2014.06.011. Epub 2014 Oct 1. Clin Res Hepatol Gastroenterol. 2014. PMID: 25281267 Review.
Regulatory T-cell therapy in liver transplantation.
Whitehouse GP, Hope A, Sanchez-Fueyo A. Whitehouse GP, et al. Transpl Int. 2017 Aug;30(8):776-784. doi: 10.1111/tri.12998. Transpl Int. 2017. PMID: 28608637 Free article. Review.
Applicability, safety, and biological activity of regulatory T cell therapy in liver transplantation.
Sánchez-Fueyo A, Whitehouse G, Grageda N, Cramp ME, Lim TY, Romano M, Thirkell S, Lowe K, Fry L, Heward J, Kerr A, Ali J, Fisher C, Lewis G, Hope A, Kodela E, Lyne M, Farzaneh F, Kordasti S, Rebollo-Mesa I, Jose Lozano J, Safinia N, Heaton N, Lechler R, Martínez-Llordella M, Lombardi G. Sánchez-Fueyo A, et al. Among authors: whitehouse g. Am J Transplant. 2020 Apr;20(4):1125-1136. doi: 10.1111/ajt.15700. Epub 2020 Feb 3. Am J Transplant. 2020. PMID: 31715056 Free PMC article. Clinical Trial.
Entecavir or tenofovir monotherapy prevents HBV recurrence in liver transplant recipients: A 5-year follow-up study after hepatitis B immunoglobulin withdrawal.
Manini MA, Whitehouse G, Bruce M, Passerini M, Lim TY, Carey I, Considine A, Lampertico P, Suddle A, Heaton N, Heneghan M, Agarwal K. Manini MA, et al. Among authors: whitehouse g. Dig Liver Dis. 2018 Sep;50(9):944-953. doi: 10.1016/j.dld.2018.03.032. Epub 2018 Apr 13. Dig Liver Dis. 2018. PMID: 29735294
151 results